** = Publications listed in SCI/SSCI/Pubmed
** Eaton, DM; Martin, TG; Kasa, M; Djalinac, N; Ljubojevic-Holzer, S; Von, Lewinski, D; Pöttler, M; Kampaengsri, T; Krumphuber, A; Scharer, K; Maechler, H; Zirlik, A; McKinsey, TA; Kirk, JA; Houser, SR; Rainer, PP; Wallner, M
HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension.
Pharmaceutics. 2022; 14(7):
Doi: 10.3390/pharmaceutics14071509
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krumphuber, A; Scharer, K; Eaton, D; Ljubojevic-Holzer, S; von Lewinski, D; Maechler, H; Zirlik, A; Houser, S; Rainer, P; Wallner, M
Functional effects of class I-selective HDAC-inhibition on human atrial myocardium
J MOL CELL CARDIOL. 2022; 173: S100-S101.
Doi: 10.1016/j.yjmcc.2022.08.201
[Poster]
Web of Science
FullText
FullText_MUG
** Scharer, K; Krumphuber, A; Eaton, DM; Ljubojevic-Holzer, S; von Lewinski, D; Machler, H; Zirlik, A; Houser, SR; Rainer, P; Wallner, M
The effects of selective HDAC-inhibition on myofibril kinetic parameters in human atrial myocardium
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 3):223-224.
[Oral Communication]
Web of Science
** Scharer, K; Krumphuber, A; Eaton, DM; Ljubojevic-Holzer, S; von Lewinski, D; Machler, H; Zirlik, A; Houser, SR; Rainer, P; Wallner, M
Functional Effects of selective HDAC Inhibition on human atrial Myocardium
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):125-126.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science